Cargando…

Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center

Detalles Bibliográficos
Autores principales: Kwon, Soo Hyun, Lee, Eun-So
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992612/
https://www.ncbi.nlm.nih.gov/pubmed/33911748
http://dx.doi.org/10.5021/ad.2020.32.3.255
_version_ 1783669411114123264
author Kwon, Soo Hyun
Lee, Eun-So
author_facet Kwon, Soo Hyun
Lee, Eun-So
author_sort Kwon, Soo Hyun
collection PubMed
description
format Online
Article
Text
id pubmed-7992612
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-79926122021-04-27 Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center Kwon, Soo Hyun Lee, Eun-So Ann Dermatol Brief Report The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2020-06 2020-04-24 /pmc/articles/PMC7992612/ /pubmed/33911748 http://dx.doi.org/10.5021/ad.2020.32.3.255 Text en Copyright © 2020 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Kwon, Soo Hyun
Lee, Eun-So
Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center
title Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center
title_full Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center
title_fullStr Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center
title_full_unstemmed Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center
title_short Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center
title_sort secukinumab response in korean patients with moderate to severe plaque-type psoriasis irrespective of previous biologic use: 1-year experience at a single center
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992612/
https://www.ncbi.nlm.nih.gov/pubmed/33911748
http://dx.doi.org/10.5021/ad.2020.32.3.255
work_keys_str_mv AT kwonsoohyun secukinumabresponseinkoreanpatientswithmoderatetosevereplaquetypepsoriasisirrespectiveofpreviousbiologicuse1yearexperienceatasinglecenter
AT leeeunso secukinumabresponseinkoreanpatientswithmoderatetosevereplaquetypepsoriasisirrespectiveofpreviousbiologicuse1yearexperienceatasinglecenter